Literature DB >> 22766901

Therapeutic plasmapheresis using membrane plasma separation.

Aditi Sinha1, Anand Narain Tiwari, Rahul Chanchlani, V Seetharamanjaneyulu, Pankaj Hari, Arvind Bagga.   

Abstract

The authors present their experience with therapeutic plasmapheresis (TPE) using membrane filters at the pediatric dialysis unit of a referral center. Between January 2006 and December 2010, 486 sessions of TPE were performed in 39 patients (range 6-17 y), chiefly for atypical hemolytic uremic syndrome (HUS, n = 22), crescentic glomerulonephritis (n = 8) and focal segmental glomerulosclerosis (n = 5). Satisfactory response was noted in 32 patients, particularly with HUS (n = 22) or crescentic glomerulonephritis (n = 6). Adverse effects included chills or urticaria (n = 8 sessions), hypocalcemia (n = 6) and hypotension (n = 5). The present findings highlight the safety, efficacy and feasibility of TPE using membrane filtration.

Entities:  

Mesh:

Year:  2012        PMID: 22766901     DOI: 10.1007/s12098-012-0779-8

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  9 in total

1.  Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.

Authors:  Zbigniew M Szczepiorkowski; Jeffrey L Winters; Nicholas Bandarenko; Haewon C Kim; Michael L Linenberger; Marisa B Marques; Ravindra Sarode; Joseph Schwartz; Robert Weinstein; Beth H Shaz
Journal:  J Clin Apher       Date:  2010       Impact factor: 2.821

2.  Plasma exchange for induction and cyclosporine A for maintenance of remission in Wegener's granulomatosis--a clinical randomized controlled trial.

Authors:  Wladimir M Szpirt; James G Heaf; Jørgen Petersen
Journal:  Nephrol Dial Transplant       Date:  2010-06-24       Impact factor: 5.992

3.  Scope and application of therapeutic apheresis: Experience from a tertiary care hospital in North India.

Authors:  Ratti Ram Sharma; Karan Saluja; Ashish Jain; Hari Krishan Dhawan; Beenu Thakral; Neelam Marwaha
Journal:  Transfus Apher Sci       Date:  2011-10-28       Impact factor: 1.764

4.  A comparison of centrifugal and membrane-based apheresis formats.

Authors:  H J Gurland; M J Lysaght; W Samtleben; B Schmidt
Journal:  Int J Artif Organs       Date:  1984-01       Impact factor: 1.595

5.  Tandem plasma-exchange and haemodialysis in a paediatric dialysis unit.

Authors:  Fabio Paglialonga; Gianluigi Ardissino; Antonietta Biasuzzi; Sara Testa; Alberto Edefonti
Journal:  Pediatr Nephrol       Date:  2011-12-02       Impact factor: 3.714

6.  Therapeutic apheresis in children: experience in a pediatric dialysis center.

Authors:  T De Palo; M Giordano; R Bellantuono; V Colella; D Troise; F Palumbo; D A Caringella
Journal:  Int J Artif Organs       Date:  2000-12       Impact factor: 1.595

Review 7.  Plasmapheresis and renal replacement therapy in children.

Authors:  Timothy E Bunchman
Journal:  Curr Opin Pediatr       Date:  2002-06       Impact factor: 2.856

8.  Treating TTP/HUS with plasma exchange: a single centre's 25-year experience.

Authors:  Brian R Forzley; Jessica M Sontrop; Jennifer J Macnab; Salina Chen; William F Clark
Journal:  Br J Haematol       Date:  2008-08-04       Impact factor: 6.998

9.  Optimization of heparin anticoagulation during membrane plasma separation.

Authors:  G M Frascà; A Buscaroli; L C Borgnino; A Vangelista
Journal:  Int J Artif Organs       Date:  1988-07       Impact factor: 1.595

  9 in total
  2 in total

Review 1.  Therapeutic plasma exchange for the treatment of pediatric renal diseases in 2013.

Authors:  Caitlin E Carter; Nadine M Benador
Journal:  Pediatr Nephrol       Date:  2013-06-29       Impact factor: 3.714

2.  Effect of plasma exchange and immunosuppressive medications on antibody titers and outcome in anti-complement factor H antibody-associated hemolytic uremic syndrome.

Authors:  Priyanka Khandelwal; Aarti Gupta; Aditi Sinha; Savita Saini; Pankaj Hari; Marie-Agnes Dragon Durey; Arvind Bagga
Journal:  Pediatr Nephrol       Date:  2014-09-13       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.